Status:
COMPLETED
CAPTURE 2 Post-Marketing Registry
Lead Sponsor:
Abbott Medical Devices
Conditions:
Carotid Artery Disease
Eligibility:
All Genders
Brief Summary
The purposes of the registry are: 1) To provide an ongoing post-market surveillance mechanism to document clinical outcomes. 2) To provide additional information that the RX ACCULINK™ and RX ACCUNET™ ...
Detailed Description
CAPTURE 2 is an amendment to the CAPTURE study and will provide a mechanism for collection of data from the RX ACCULINK and RX ACCUNET Systems, when used by a broad group of physicians under commercia...
Eligibility Criteria
Inclusion
- Informed Consent for data collection.
- Intent to use the RX ACCULINK and RX ACCUNET to treat carotid artery disease.
Exclusion
- none.
Key Trial Info
Start Date :
March 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2010
Estimated Enrollment :
6426 Patients enrolled
Trial Details
Trial ID
NCT00302237
Start Date
March 1 2006
End Date
May 1 2010
Last Update
December 13 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Abbott Vascular
Santa Clara, California, United States, 95054